|
11.
|
|
7 p, 587.0 KB |
Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
/
Julià Cano, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
López Lasanta, María (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Blanco-García, F.J (Complejo Hospitalario Universitario de A Coruña) ;
Gómez Moruno, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Haro, Immaculada (Institut de Química Avançada de Catalunya) ;
Mas, Antonio Juan (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ;
Erra Duran, Alba (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
García Vivar, María Luz (Hospital de Basurto (Bilbao, Biscaia)) ;
Monfort, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Sánchez-Fernández, Simón (Hospital General La Mancha Centro (Ciutat Reial)) ;
González, Isidoro (Hospital Universitario de la Princesa (Madrid)) ;
Alperi-López, Mercedes (Hospital Universitario Central de Asturias) ;
Castellanos-Moreira, Raúl (Fundació Clínic per a la Recerca Biomèdica) ;
Fernández-Nebro, Antonio (Hospital Regional Universitario de Málaga) ;
Díaz Torne, César (Institut d'Investigació Biomèdica Sant Pau) ;
Palau, Núria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lastra, Raquel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lladós, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sanmartí, Raimon (Fundació Clínic Recerca Biomèdica) ;
Marsal, Sara (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Background: Blocking of the Tumor Necrosis Factor (TNF) activity is a successful therapeutic approach for 50-60% of rheumatoid arthritis (RA) patients. However, there are yet no biomarkers to stratify patients for anti-TNF therapy. [...]
2021 -  10.1186/s12891-021-04248-y
BMC musculoskeletal disorders, Vol. 22 Núm. 1 (december 2021) , p. 372
|
|
|
12.
|
|
18 p, 3.8 MB |
Integrative epigenomics in Sjögren's syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
/
Teruel, María (Universidad de Granada) ;
Barturen, Guillermo (Universidad de Granada) ;
Martínez-Bueno, Manuel (Universidad de Granada) ;
Castellini-Pérez, Olivia (Universidad de Granada) ;
Barroso-Gil, Miguel (Universidad de Granada) ;
Povedano, Elena (Universidad de Granada) ;
Kerick, Martin (Consejo Superior de Investigaciones Científicas) ;
Català-Moll, Francesc (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Makowska, Zuzanna (Bayer Pharma) ;
Buttgereit, Anne (Bayer Pharma) ;
Beretta, Lorenzo (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano) ;
Vigone, Barbara (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano) ;
Pers, Jacques Olivier (Hospital de la Cavale Blanche) ;
Saraux, Alain (Hospital de la Cavale Blanche) ;
Devauchelle-Pensec, Valérie (Hospital de la Cavale Blanche) ;
Cornec, Divi (Hospital de la Cavale Blanche) ;
Jousse-Joulin, Sandrine (Hospital de la Cavale Blanche) ;
Lauwerys, Bernard (Université catholique de Louvain) ;
Ducreux, Julie (Université Catholique de Louvain) ;
Maudoux, Anne Lise (Université catholique de Louvain) ;
Vasconcelos, Carlos (Centro Hospitalar do Porto) ;
Tavares, Ana (Centro Hospitalar do Porto) ;
Neves, Esmeralda (Centro Hospitalar e Universitário do Porto) ;
Faria, Raquel (Centro Hospitalar do Porto) ;
Brandão, Mariana (Centro Hospitalar do Porto) ;
Campar, Ana (Centro Hospitalar do Porto) ;
Marinho, António (Centro Hospitalar do Porto) ;
Farinha, Fátima (Centro Hospitalar do Porto) ;
Almeida, Isabel (Centro Hospitalar do Porto) ;
Gozalez-Gay Mantecón, Miguel Angel (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Blanco, Ricardo (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Corrales Martínez, Alfonso (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Cervera, Ricard (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Rodríguez-Pintó, Ignasi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Espinosa, Gerard (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Lories, Rik (Katholieke Universiteit Leuven) ;
De Langhe, Ellen (University Hospitals Leuven (Bèlgica)) ;
Hunzelmann, Nicolas (Klinikum der Universitaet zu Koeln) ;
Belz, Doreen (Klinikum der Universitaet zu Koeln) ;
Witte, Torsten (Medical University Hannover) ;
Baerlecken, Niklas (Medizinische Hochschule Hannover) ;
Stummvoll, Georg (Medical University Vienna) ;
Zauner, Michael (Medical University Vienna) ;
Lehner, Michaela (Medical University Vienna) ;
Collantes Estevéz, Eduardo (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Ortega-Castro, Rafaela (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Aguirre, Mª Angeles (Hospital Universitario "Reina Sofía" (Còrdova, Espanya)) ;
Escudero-Contreras, Alejandro (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Castro-Villegas, Ma Carmen (Hospital Universitario San Cecilio (Granada)) ;
Ortego, Norberto (Complejo Hospitalario Universitario de Granada) ;
Fernández Roldán, María Concepción (Complejo Hospitalario Universitario de Granada) ;
Raya, Enrique (Complejo Hospitalario Universitario de Granada) ;
Jiménez Moleón, Inmaculada (Complejo Hospitalario Universitario de Granada) ;
de Ramon, Enrique (Hospital Regional Universitario de Málaga) ;
Díaz Quintero, Isabel (Hospital Regional Universitario de Málaga) ;
Meroni, Pier Luigi (Università degli studi di Milano) ;
Gerosa, Maria (Università degli studi di Milano) ;
Schioppo, Tommaso (Università degli studi di Milano) ;
Artusi, Carolina (Università degli studi di Milano) ;
Chizzolini, Carlo (University Hospital and School of Medicine) ;
Zuber, Aleksandra (Hospitaux Universitaires de Genève) ;
Wynar, Donatienne (Hospitaux Universitaires de Genève) ;
Kovács, Laszló (University of Szeged) ;
Balog, Attila (University of Szeged) ;
Deák, Magdolna (University of Szeged) ;
Bocskai, Márta (University of Szeged) ;
Dulic, Sonja (University of Szeged) ;
Kádár, Gabriella (University of Szeged) ;
Hiepe, Falk (Charite) ;
Gerl, Velia (Charité University Hospital) ;
Thiel, Silvia (Charité University Hospital) ;
Rodriguez Maresca, Manuel (Andalusian Public Health System Biobank) ;
López-Berrio, Antonio (Andalusian Public Health System Biobank) ;
Aguilar-Quesada, Rocío (Andalusian Public Health System Biobank) ;
Navarro-Linares, Héctor (Andalusian Public Health System Biobank) ;
Álvarez, Montserrat (Immunology and Allergy. University Hospital and School of Medicine) ;
Alvarez‑Errico, Damiana (Institut d'Investigació Biomèdica de Bellvitge) ;
Azevedo, Nancy (Centro Hospitalar e Universitário do Porto) ;
Barbarroja, Nuria (Bayer Pharma) ;
Buttgereit, Anne (Bayer Pharma) ;
Cheng, Qingyu (Charité University Hospital) ;
Chizzolini, Carlo (University Hospital and School of Medicine) ;
Cremer, Jonathan (KU Leuven) ;
De Groof, Aurélie (Université Catholique de Louvain) ;
De Langhe, Ellen (University Hospitals Leuven (Bèlgica)) ;
Ducreux, Julie (Université Catholique de Louvain) ;
Dufour, Aleksandra (University Hospital and School of Medicine) ;
Gerl, Velia (Charité University Hospital) ;
Hernandez‑Fuentes, Maria (UCB) ;
Khodadadi, Laleh (Charité University Hospital) ;
Kniesch, Katja (Medical University Hannover) ;
Li, Tianlu (Charité University Hospital) ;
Lopez‑Pedrera, Chary (Université Catholique de Louvain) ;
Makowska, Zuzanna (Bayer Pharma) ;
Marañón, Concepción (Universidad de Granada) ;
Muchmore, Brian (Universidad de Granada) ;
Neves, Esmeralda (Centro Hospitalar e Universitário do Porto) ;
Rouvière, Bénédicte (University of Brest) ;
Simon, Quentin (University of Brest) ;
Trombetta, Elena (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano) ;
Varela, Nieves (Medical University Hannover) ;
Witte, Torsten (Medical University Hannover) ;
Pers, Jacques Olivier (Hospital de la Cavale Blanche) ;
Marañón, Concepción (Universidad de Granada) ;
Ballestar, Esteban (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Martin, Javier (Consejo Superior de Investigaciones Científicas) ;
Carnero-Montoro, Elena (Universidad de Granada) ;
Alarcón-Riquelme, Marta E (Karolinska Institutet (Estocolm, Suècia)) ;
Universitat Autònoma de Barcelona
Primary Sjögren's syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration and damage of exocrine salivary and lacrimal glands. The etiology of SS is complex with environmental triggers and genetic factors involved. [...]
2021 - 10.1038/s41598-021-01324-0
Scientific reports, Vol. 11 Núm. 1 (december 2021) , p. 23292
|
|
|
13.
|
|
145 p, 8.5 MB |
Estudio de biomarcadores en pacientes con Síndrome de Guillain-Barré
/
Lleixà Rodríguez, Cinta ;
Querol, Luis, dir. ;
Sendra, Illa Isabel, dir.
La síndrome de Guillain-Barré (SGB) és una neuropatia inflamatòria aguda amb una presentació heterogènia. Es considera una malaltia autoimmune postinfecciosa paradigmàtica. Encara que existeix evidència que recolza el paper dels autoanticossos en la seva patogènesi, i els anticossos antigangliòsid es detecten fins a la meitat dels pacients amb SGB, els antígens diana segueixen sent desconeguts en una proporció substancial de pacients. [...]
El síndrome de Guillain-Barré (SGB) es una neuropatía inflamatoria aguda con una presentación heterogénea. Se considera una enfermedad autoinmune postinfecciosa paradigmática. Aunque existe evidencia que apoya el papel de los autoanticuerpos en su patogénesis, y los anticuerpos anti-gangliósido se detectan hasta en la mitad de los pacientes con SGB, los antígenos diana siguen siendo desconocidos en una proporción sustancial de pacientes. [...]
Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy with a heterogeneous presentation. It is considered a paradigmatic post-infectious autoimmune disease. Although there is evidence to support the role of autoantibodies in its pathogenesis, and anti-ganglioside antibodies are detected in up to half of GBS patients, the target antigens remain unknown in a substantial proportion of patients. [...]
2022
|
|
|
14.
|
|
13 p, 1.9 MB |
Autoantibody screening in Guillain-Barré syndrome
/
Lleixà, Cinta (Institut d'Investigació Biomèdica Sant Pau) ;
Martín-Aguilar, Lorena (Institut d'Investigació Biomèdica Sant Pau) ;
Pascual-Goñi, Elba (Institut d'Investigació Biomèdica Sant Pau) ;
Franco-Leyva, Teresa (Institut d'Investigació Biomèdica Sant Pau) ;
Caballero-Ávila, Marta (Institut d'Investigació Biomèdica Sant Pau) ;
de Luna Salva, Noemí (Institut d'Investigació Biomèdica Sant Pau) ;
Gallardo, Eduard (Institut d'Investigació Biomèdica Sant Pau) ;
Suarez-Calvet, Xavier (Institut d'Investigació Biomèdica Sant Pau) ;
Martínez-Martínez, Laura (Institut d'Investigació Biomèdica Sant Pau) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Rojas-Garcia, Ricard (Institut d'Investigació Biomèdica Sant Pau) ;
Cortés-Vicente, Elena (Institut d'Investigació Biomèdica Sant Pau) ;
Turón, Joana (Institut d'Investigació Biomèdica Sant Pau) ;
Casasnovas, Carlos (Institut d'Investigació Biomèdica de Bellvitge) ;
Homedes, C. (Hospital Universitari de Bellvitge) ;
Gutiérrez-Gutiérrez, Gerardo (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ;
Jimeno-Montero, M. C. (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ;
Berciano, José (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Sedano-Tous, M. J. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
García-Sobrino, Tania (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ;
Pardo, Julio (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ;
Márquez-Infante, C. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Rojas-Marcos, I. (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Jericó, Ivonne (Complejo Hospitalario de Navarra) ;
Martínez-Hernández, E. (Hospital Clínic i Provincial de Barcelona) ;
Morís, Germán (Hospital Universitario Central de Asturias) ;
Domínguez-González, C. (Hospital Universitario 12 de Octubre (Madrid)) ;
Juarez, Candido (Institut d'Investigació Biomèdica Sant Pau) ;
Illa, Isabel (Institut d'Investigació Biomèdica Sant Pau) ;
Querol, Luis (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Background: Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy with a heterogeneous presentation. Although some evidences support the role of autoantibodies in its pathogenesis, the target antigens remain unknown in a substantial proportion of GBS patients. [...]
2021 - 10.1186/s12974-021-02301-0
Journal of neuroinflammation, Vol. 18 Núm. 1 (december 2021) , p. 251
|
|
|
15.
|
|
7 p, 1.0 MB |
The European ME/CFS Biomarker Landscape project : an initiative of the European network EUROMENE
/
Scheibenbogen, Carmen (Charité - Universitätsmedizin Berlin) ;
Freitag, Helma (Charité - Universitätsmedizin Berlin) ;
Blanco, Julià (Universitat de Vic) ;
Capelli, Enrica (University of Pavia) ;
Lacerda, Eliana (London School of Hygiene & Tropical Medicine) ;
Authier, Jerome (Paris Est-Creteil University) ;
Meeus, Mira (University of Antwerp) ;
Castro-Marrero, Jesús (Hospital Universitari Vall d'Hebron) ;
Nora-Krukle, Zaiga (Riga Stradins University) ;
Oltra, Elisa (Centro de Investigación Príncipe Felipe (València)) ;
Strand, Elin Bolle (Copenhagen University Hospital Rigshospitalet) ;
Shikova, Evelina (National Center of Infectious and Parasitic Diseases) ;
Sekulic, Slobodan (Medical Faculty Novi Sad) ;
Murovska, Modra (Riga Stradins University) ;
Universitat Autònoma de Barcelona
Myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) is a common and severe disease with a considerable social and economic impact. So far, the etiology is not known, and neither a diagnostic marker nor licensed treatments are available yet. [...]
2017 - 10.1186/s12967-017-1263-z
Journal of translational medicine, Vol. 15 (july 2017)
|
|
|
16.
|
|
14 p, 549.4 KB |
A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies
/
Oldroyd, Alexander G. S. (Salford Royal NHS Foundation Trust) ;
Allard, Andrew B. (Royal National Hospital for Rheumatic Diseases) ;
Callen, Jeffrey P. (University of Louisville) ;
Chinoy, Hector (Salford Royal NHS Foundation Trust) ;
Chung, Lorinda (Palo Alto Health Care System) ;
Fiorentino, David (Stanford University) ;
George, Michael D. (University of Pennsylvania) ;
Gordon, Patrick (King's College Hospital NHS Foundation Trust) ;
Kolstad, Kate (Stanford University) ;
Kurtzman, Drew J. B. (Wright State University) ;
Machado, Pedro M. (London North West University Healthcare NHS Trust) ;
McHugh, Neil J. (University of Bath) ;
Postolova, Anna (Stanford Health Care) ;
Selva-O'Callaghan, Albert (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Schmidt, Jens (Neuromuscular Centre) ;
Tansley, Sarah (Neuromuscular Centre) ;
Vleugels, Ruth Ann (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ;
Werth, Victoria P. (Corporal Michael J. Crescenz VA Medical Center) ;
Aggarwal, Rohit (University of Pittsburgh) ;
Universitat Autònoma de Barcelona
To identify clinical factors associated with cancer risk in the idiopathic inflammatory myopathies (IIMs) and to systematically review the existing evidence related to cancer screening. A systematic literature search was carried out on Medline, Embase and Scopus. [...]
2021 - 10.1093/rheumatology/keab166
Rheumatology, Vol. 60 (february 2021) , p. 2615-2628
|
|
|
17.
|
|
15 p, 1.9 MB |
Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria
/
Kolkhir, Pavel (Charité - Universitätsmedizin Berlin) ;
Altrichter, Sabine (Charité - Universitätsmedizin Berlin) ;
Asero, Riccardo (Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano) ;
Daschner, Alvaro (Instituto de Investigación Hospital Universitario de la Princesa) ;
Ferrer, Marta (Instituto de Investigación Sanitaria de Navarra) ;
Giménez-Arnau, Ana M 1961- (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Hawro, Tomasz (Charité - Universitätsmedizin Berlin) ;
Jakob, Thilo (Justus Liebig Universität Giessen) ;
Kinaciyan, Tamar (Medical University of Vienna) ;
Kromminga, Arno (Bioagilytix Europe GmbH, Hamburg) ;
Konstantinou, George (424 General Military Training Hospital, Thessaloniki) ;
Makris, Michael (University General Hospital Attikon (Haidari, Grècia)) ;
Metz, Martin (Charité - Universitätsmedizin Berlin) ;
Skov, Per Stahl (RefLab ApS, Copenhagen) ;
Staubach, Petra (University Medical Center Mainz) ;
Sussman, Gordon (University of Toronto) ;
Zhang, Ke (David Geffen School of Medicine at UCLA) ;
Maurer, Marcus (Charité - Universitätsmedizin Berlin)
Patients with chronic spontaneous urticaria (CSU) have an increased risk for comorbid autoimmune diseases. In this retrospective multicenter study of CSU patients, we evaluated clinical and laboratory features of CSU associated with a higher risk of comorbid autoimmune diseases. [...]
2021 - 10.4168/aair.2021.13.4.545
Allergy, Asthma & Immunology Research, Vol. 13 (february 2021) , p. 545-559
|
|
|
18.
|
|
17 p, 2.5 MB |
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
/
Bastard, Paul (The Rockefeller University. St. Giles Laboratory of Human Genetics of Infectious Diseases) ;
Rosen, Lindsey B. (National Institute of Allergy and Infectious Diseases (Maryland, Estats Units d'Amèrica)) ;
Zhang, Qian (The Rockefeller University. St. Giles Laboratory of Human Genetics of Infectious Diseases) ;
Michailidis, Eleftherios (The Rockefeller University. Laboratory of Virology and Infectious Disease) ;
Hoffmann, Hans-Heinrich (The Rockefeller University. Laboratory of Virology and Infectious Disease) ;
Zhang, Yu (National Institute of Allergy and Infectious Diseases (Maryland, Estats Units d'Amèrica)) ;
Dorgham, Karim (Sorbonne Université. Centre d'Immunologie et des Maladies Infectieuses) ;
Philippot, Quentin (University of Paris. Imagine Institute) ;
Rosain, Jérémie (University of Paris. Imagine Institute) ;
Béziat, Vivien (The Rockefeller University. St. Giles Laboratory of Human Genetics of Infectious Diseases) ;
Manry, Jeremy (University of Paris. Imagine Institute) ;
Shaw, Elana (National Institute of Allergy and Infectious Diseases (Maryland, Estats Units d'Amèrica)) ;
Haljasmägi, Liis (University of Tartu. Institute of Biomedicine and Translational Medicine) ;
Peterson, Pärt (University of Tartu. Institute of Biomedicine and Translational Medicine) ;
Lorenzo, Lazaro (University of Paris. Imagine Institute) ;
Bizien, Lucy (University of Paris. Imagine Institute) ;
Trouillet-Assant, Sophie (Lyon University. International Center of Research in Infectiology) ;
Dobbs, Kerry (National Institute of Allergy and Infectious Diseases (Maryland, Estats Units d'Amèrica)) ;
Almeida de Jesus, Adriana (National Institute of Allergy and Infectious Diseases (Maryland, Estats Units d'Amèrica)) ;
Belot, Alexandre (Lyon Immunopathology Federation. Hospices Civils de Lyon) ;
Kallaste, Anne (Internal Medicine Clinic. Tartu University Hospital) ;
Catherinot, Emilie (Hôpital Foch) ;
Tandjaoui-Lambiotte, Yacine (Avicenne Hospital. Assistance Publique Hôpitaux de Paris) ;
Le Pen, Jérémie (The Rockefeller University. Laboratory of Virology and Infectious Disease) ;
Kerner, Gaspard (University of Paris. Imagine Institute) ;
Bigio, Benedetta (The Rockefeller University. St. Giles Laboratory of Human Genetics of Infectious Diseases) ;
Seeleuthner, Yoann (University of Paris. Imagine Institute) ;
Yang, Rui (The Rockefeller University. St. Giles Laboratory of Human Genetics of Infectious Diseases) ;
Bolze, Alexandre (Helix) ;
Spaan, András N. (University Medical Center Utrecht) ;
Delmonte, Ottavia M. (National Institute of Allergy and Infectious Diseases (Maryland, Estats Units d'Amèrica)) ;
Abers, Michael S. (National Institute of Allergy and Infectious Diseases (Maryland, Estats Units d'Amèrica)) ;
Aiuti, Alessandro (Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS)) ;
Casari, Giorgio (Medical Genetics. IRCCS Ospedale San Raffaele) ;
Lampasona, Vito (Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS)) ;
Piemonti, Lorenzo (Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS)) ;
Ciceri, Fabio (Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS)) ;
Bilguvar, Kaya (Yale University School of Medicine. Department of Genetics) ;
Lifton, Richard P. (Rockefeller University. Laboratory of Human Genetics and Genomics) ;
Vasse, Marc (Consorcio Hospital. General Universitario) ;
Smadja, David M. (Paris University. European Georges Pompidou Hospital) ;
Migaud, Mélanie (University of Paris. Imagine Institute) ;
Hadjadj, Jérome (Hôpital Cochin. Department of Internal Medicine) ;
Terrier, Benjamin (Université de Paris. Department of Internal Medicine) ;
Duffy, Darragh (Pasteur Institute) ;
Quintana-Murci, Lluis (Institut Pasteur. Collège de France) ;
van de Beek, Diederik (Amsterdam UMC. University Medical Center) ;
Roussel, Lucie (McGill University Health Centre) ;
Vinh, Donald C. (McGill University Health Centre) ;
Tangye, Stuart (Garvan Institute of Medical Research (Darlinghurst, Austràlia)) ;
Haerynck, Filomeen (Ghent University Hospital. (Bèlgica)) ;
Dalmau, David (Fundació Docència i Recerca Mútua Terrassa) ;
Martínez Picado, Francisco Javier (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Brodin, Petter (Karolinska Institutet (Estocolm, Suècia)) ;
Nussenzweig, Michel (Howard Hughes Medical Institute) ;
Boisson-Dupuis, Stephanie (The Rockefeller University. St. Giles Laboratory of Human Genetics of Infectious Diseases) ;
Rodríguez-Gallego, Carlos (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Vogt, Guillaume (University of Paris. Neglected Human Genetics Laboratory) ;
Mogensen, Trine Hyrup (Aarhus University) ;
Oler, Andrew J. (Bioinformatics and Computational Biosciences Branch. Office of Cyber Infrastructure and Computational Biology. NIAID. NIH) ;
Gu, Jingwen (Bioinformatics and Computational Biosciences Branch. Office of Cyber Infrastructure and Computational Biology. NIAID. NIH) ;
Burbelo, Peter D. (Division of Intramural Research. National Institute of Dental Craniofacial Research (NIDCR). NIH) ;
Cohen, Jeffrey I. (Laboratory of Infectious Diseases. Division of Intramural Research. NIAID. NIH) ;
Biondi, Andrea (Pediatric Department. Centro Tettamanti-European Reference Network PaedCan. EuroBloodNet. MetabERN-University of Milano-Bicocca-Fondazione MBBMOspedale) ;
Bettini, Laura Rachele (Pediatric Department. Centro Tettamanti-European Reference Network PaedCan. EuroBloodNet. MetabERN-University of Milano-Bicocca-Fondazione MBBMOspedale) ;
D'Angio, Mariella (University of Milano-Bicocca. Pediatric Department) ;
Bonfanti, Paolo (University of Milano-Bicocca. Department of Infectious Diseases) ;
Rossignol, Patrick (University of Lorraine. Plurithematic Clinical Investigation Centre) ;
Mayaux, Julien (APHP Pitié-Salpêtrière Hospital) ;
Rieux-Laucat, Frédéric (Laboratory of Immunogenetics of Pediatric Autoimmune Diseases. INSERM. UMR 1163. University of Paris. Imagine Institute) ;
Husebye, Eystein (Karolinska Institutet (Estocolm, Suècia). Department of Medicine) ;
Fusco, Francesca (Institute of Genetics and Biophysics 'Adriano Buzzati-Traverso'. IGB-CNR) ;
Ursini, Matilde Valeria (Institute of Genetics and Biophysics 'Adriano Buzzati-Traverso'. IGB-CNR) ;
Imberti, Luisa (Centro di Ricerca Emato-oncologica AIL (CREA) Laboratory. Diagnostic Department. ASST Spedali Civili di Brescia) ;
Sottini, Alessandra (Centro di Ricerca Emato-oncologica AIL (CREA) Laboratory. Diagnostic Department. ASST Spedali Civili di Brescia) ;
Paghera, Simone (Centro di Ricerca Emato-oncologica AIL (CREA) Laboratory. Diagnostic Department. ASST Spedali Civili di Brescia) ;
Quiros-Roldan, Eugenia (Department of Infectious and Tropical Diseases. University of Brescia. ASST Spedali di Brescia) ;
Rossi, Camillo (Direzione Sanitaria. ASST Spedali Civili di Brescia) ;
Castagnoli, Riccardo (Department of Pediatrics. Fondazione IRCCS Policlinico San Matteo. University of Pavia) ;
Montagna, Daniela (Department of Clinical. Surgical. Diagnostic and Pediatric Sciences. University of Pavia) ;
Licari, Amelia (Department of Pediatrics. Fondazione IRCCS Policlinico San Matteo. University of Pavia) ;
Marseglia, Gian Luigi (Department of Pediatrics. Fondazione IRCCS Policlinico San Matteo. University of Pavia) ;
Duval, Xavier (Centre d'Investigation Clinique. Inserm CIC 1425. Hôpital Bichat Claude Bernard. APHP) ;
Ghosn, Jade (Hôpital Bichat) ;
Tsang, John S. (Multiscale Systems Biology Section. Laboratory of Immune System Biology. NIAID. NIH) ;
Goldbach-Mansky, Raphaela (National Institute of Allergy and Infectious Diseases (Maryland, Estats Units d'Amèrica)) ;
Kisand, Kai (Institute of Biomedicine and Translational Medicine. University of Tartu) ;
Lionakis, Michail S. (National Institute of Allergy and Infectious Diseases (Maryland, Estats Units d'Amèrica)) ;
Puel, Anne (St. Giles Laboratory of Human Genetics of Infectious Diseases. Rockefeller Branch. The Rockefeller University) ;
Zhang, Shein-Ying (St. Giles Laboratory of Human Genetics of Infectious Diseases. Rockefeller Branch. The Rockefeller University) ;
Holland, Steven M. (National Institute of Allergy and Infectious Diseases (Maryland, Estats Units d'Amèrica)) ;
Gorochov, Guy (Département d'Immunologie. AP-HP. Hôpital Pitié-Salpétrière) ;
Jouanguy, Emmanuelle (St. Giles Laboratory of Human Genetics of Infectious Diseases. Rockefeller Branch. The Rockefeller University) ;
Rice, Charles M. (Laboratory of Virology and Infectious Disease. The Rockefeller University) ;
Cobat, Aurélie (St. Giles Laboratory of Human Genetics of Infectious Diseases. Rockefeller Branch. The Rockefeller University) ;
Notarangelo, Luigi (National Institute of Allergy and Infectious Diseases (Maryland, Estats Units d'Amèrica)) ;
Abel, Laurent (St. Giles Laboratory of Human Genetics of Infectious Diseases. Rockefeller Branch. The Rockefeller University) ;
Su, Helen C. (National Institute of Allergy and Infectious Diseases (Maryland, Estats Units d'Amèrica)) ;
Casanova, Jean-Laurent (Pediatric Hematology and Immunology Unit. Necker Hospital for Sick Children. AP-HP) ;
The University of Hong Kong
HGID Lab ;
The University of Hong Kong
NIAID-USUHS Immune Response to COVID Group ;
COVID Clinicians ;
COVID-STORM Clinicians ;
Imagine COVID Group ;
French COVID Cohort Study Group ;
The Milieu Intérieur Consortium ;
CoV-Contact Cohort ;
Amsterdam UMC Covid-19 Biobank ;
COVID Human Genetic Effort ;
Universitat Autònoma de Barcelona
Interindividual clinical variability in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is vast. We report that at least 101 of 987 patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia had neutralizing immunoglobulin G (IgG) autoantibodies (auto-Abs) against interferon-w (IFN-w) (13 patients), against the 13 types of IFN-a (36), or against both (52) at the onset of critical disease; a few also had auto-Abs against the other three type I IFNs. [...]
2020 - 10.1126/science.abd4585
Science, Vol. 370 Núm. 6515 (september 2020) , p. eabd4585
|
|
|
19.
|
|
|
20.
|
|
5 p, 1.1 MB |
Caveats and pitfalls of SOX1 autoantibody testing with a commercial line blot assay in paraneoplastic neurological investigations
/
Ruiz-García, R. (Institut d'Investigació Biomèdica de Bellvitge) ;
Martínez-Hernández, E. (Hospital Clínic i Provincial de Barcelona) ;
García-Ormaechea, M. (Institut d'Investigació Biomèdica de Bellvitge) ;
Español-Rego, M. (Institut d'Investigació Biomèdica de Bellvitge) ;
Sabater, L. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Querol, Luis (Institut d'Investigació Biomèdica Sant Pau) ;
Illa, Isabel (Institut d'Investigació Biomèdica Sant Pau) ;
Dalmau, J. (Department of Neurology. University of Pennsylvania) ;
Graus Ribas, Francesc (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Universitat Autònoma de Barcelona
SOX1 autoantibodies are considered markers of small cell lung cancer (SCLC) and paraneoplastic neurological syndromes (PNS) and are usually determined by commercial line blot in many clinical services. [...]
2019 - 10.3389/fimmu.2019.00769
Frontiers in immunology, Vol. 10 Núm. APR (2019) , p. 769
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
